CVRx (NASDAQ:CVRX – Get Free Report) is expected to post its quarterly earnings results before the market opens on Thursday, January 23rd. Analysts expect CVRx to post earnings of ($0.39) per share and revenue of $14,850.00 billion for the quarter. CVRx has set its Q4 2024 guidance at EPS and its FY 2024 guidance at EPS.
CVRx (NASDAQ:CVRX – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.57) EPS for the quarter, missing the consensus estimate of ($0.45) by ($0.12). The company had revenue of $13.37 million during the quarter, compared to the consensus estimate of $13.28 million. CVRx had a negative return on equity of 89.06% and a negative net margin of 123.75%. During the same period last year, the business earned ($0.43) EPS. On average, analysts expect CVRx to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
CVRx Trading Up 1.8 %
Shares of NASDAQ:CVRX opened at $17.62 on Tuesday. The stock has a 50 day moving average of $14.16 and a 200 day moving average of $11.16. The company has a market cap of $427.46 million, a PE ratio of -6.53 and a beta of 1.26. CVRx has a 12-month low of $6.40 and a 12-month high of $29.23. The company has a current ratio of 11.32, a quick ratio of 10.23 and a debt-to-equity ratio of 0.76.
Analysts Set New Price Targets
About CVRx
CVRx, Inc, a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure.
See Also
- Five stocks we like better than CVRx
- CD Calculator: Certificate of Deposit Calculator
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is a Death Cross in Stocks?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for CVRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVRx and related companies with MarketBeat.com's FREE daily email newsletter.